Login/Sign Up
What is the recommended clinical management for a 17-year-old patient experiencing severe skin rashes after transitioning from oxcarbazepine to levetiracetam, currently dosed at 250 mg in the morning and 2000 mg in the evening for seizure control?
What is the recommended clinical management for a 17-year-old patient experiencing severe skin rashes after transitioning from oxcarbazepine to levetiracetam, currently dosed at 250 mg in the morning and 2000 mg in the evening for seizure control?
Answered 2 days ago